<DOC>
	<DOCNO>NCT00553228</DOCNO>
	<brief_summary>The purpose study ass whether immunization pertussis mid third trimester pregnancy provide passive protection infant transfer IgG transplacentally transfer secretory IgA ( possibly IgG ) breast milk , sufficient protect infant pertussis disease critical neonatal period , without suppress infant 's immune response active immunization disease</brief_summary>
	<brief_title>Pertussis Maternal Immunization Study</brief_title>
	<detailed_description>The purpose study ass potential provide initial immunological protection neonate provide passive placentally transfer serum antibody breast milk antibody pertussis antigen ( PT , FHA , PRN , FIM ) . This accomplished - determine rate maternal antibody decline time immunization 12 month postpartum measure antibody level serum , saliva , breast milk specify interval ; - determining level antibody transfer neonate relative interval immunization delivery ; - comparing level transplacentally transfer antibody achieve first , second , third dose primary immunization series ; - determine whether maternal immunization interferes active antibody production follow license DTaP-IPV-Hib infant woman immunize mid third trimester pregnancy .</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Pregnant woman 18 year age . Women , ≥30 &lt; 32 week gestation , low risk complication determine obstetrical algorithm identification eligible subject obstetrical risk assessment form . Signed , informed consent . Failure meet eligibility criterion determine obstetrical algorithm identification eligible subject obstetrical risk assessment form . History significant medical disorder ( bleed disorder , cancer , autoimmune disease , immunodeficiency ( include HIVinfected individual , transplant recipient ) , seizure disorder significant psychiatric illness , drug alcohol dependence ) . Receipt highdose daily corticosteroid ( inhaled steroid acceptable ) within 2 week study entry . High dose define dose ≥20 mg prednisone daily equivalent . History physiciandiagnosed laboratoryconfirmed pertussis within past 5 year . Personal history ( verbal document ) ever receive Tdap . Personal history ( verbal document ) receive Td immunization within past 2 year . History febrile illness ( &gt; 37.8ºC orally ) within past 72 hour ( immunization may defer ) . History sensitivity component Tdap . Receipt blood product immunoglobulin within 3 month study entry ( except RHnegative woman receive immunoglobulin pregnancy eligible ) . Receipt vaccine within 2 week study vaccine ( except influenza vaccine may give concurrently ) . Failure give write , informed consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>maternal immunization</keyword>
	<keyword>whooping cough</keyword>
	<keyword>pertussis</keyword>
</DOC>